pfizer covid - Search News

News

Pfizer raises 2025 profit forecast

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

Yahoo Finance · 57m

Pfizer shares rise 3% after upping profit forecast for 2025

Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales for heart disease drug Vyndaqel (tafamidis) and blood thinner Eliquis (apixaban),

The Wall Street Journal on MSN · 1h

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

Pfizer, Q2 and PFE

AOL · 3h

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.

Zacks.com on MSN · 4h

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates

Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.

Seeking Alpha on MSN · 6h

Earnings Snapshot: Pfizer (PFE) tops Q2 results, raises FY2025 EPS outlook

Pfizer: Lack Of Enthusiasm Shouldn't Surprise You Pfizer's Comeback Is Underway Pfizer Non-GAAP EPS of $0.78 beats by $0.21, revenue of $14.65B beats by $1.12B, raises FY25 guidance Pfizer’s strong EP

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Pfizer Profits Boosted By Covid-19 Products, Lower Expenses

Pfizer reported a jump in second-quarter profits Tuesday behind higher sales of Covid-19 products and some other pharmaceuticals, while also benefiting from lower expenses.

2hon MSN

Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand

CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

37m

Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

Schaeffer's Investment Research2h

Pfizer Stock Pops on Q2 Beat-and-Raise

Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...

4don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results